SCHEMBL2927079

SCHEMBL2927079

CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(-c4cnco4)c3)cc2F)n(-c2cccc(CO)c2)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 7/20 0.62
BRAF P15056 13/20 0.54
KCNH2 Q12809 1/20 0.54
MAPK13 O15264 2/20 0.53
RIPK1 Q13546 2/20 0.53
PLK4 O00444 1/20 0.53
ACOX3 O15254 1/20 0.53
MAP3K7 O43318 1/20 0.53
DYRK3 O43781 1/20 0.53
JAK2 O60674 1/20 0.53
ERN1 O75460 1/20 0.53
RPS6KA4 O75676 1/20 0.53
STK10 O94804 1/20 0.53
MAP4K4 O95819 1/20 0.53
ABL1 P00519 1/20 0.53
RAF1 P04049 1/20 0.53
NTRK1 P04629 1/20 0.53
LCK P06239 1/20 0.53
FYN P06241 1/20 0.53
CDK1 P06493 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2923736 0.88 MAPK14 (0.64) MAPK14BRAFKCNH2MAPK13RIPK1
SCHEMBL5058610 0.87 MAPK14 (0.65) MAPK14BRAFKCNH2MAPK13RIPK1
SCHEMBL5067797 0.87 MAPK14 (0.61) MAPK14BRAFKCNH2MAPK13RIPK1
SCHEMBL5062836 0.86 MAPK14 (0.63) MAPK14BRAFKCNH2MAPK13RIPK1
SCHEMBL1128969 0.86 MAPK14 (0.69) MAPK14BRAFKCNH2MAPK13RIPK1
SCHEMBL5058613 0.86 MAPK14 (0.62) MAPK14BRAFKCNH2MAPK13RIPK1
SCHEMBL2927715 0.86 MAPK14 (0.63) MAPK14BRAFKCNH2MAPK13RIPK1
SCHEMBL2923605 0.85 MAPK14 (0.61) MAPK14BRAFKCNH2MAPK13RIPK1
SCHEMBL5067783 0.85 MAPK14 (0.62) MAPK14BRAFMAPK13RIPK1PLK4
SCHEMBL3634875 0.85 MAPK14 (0.68) MAPK14BRAFMAPK13RIPK1PLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2481736-A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases Deciphera Pharmaceuticals, LLC. (US) 2012-08-01 EP disclosed
EP-2148677-A1 KINASE INHIBITORS USEFUL FOR THE TREATMENT OF MYLEOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES Deciphera Pharmaceuticals, LLC. (US) 2010-02-03 EP disclosed
WO-2008131276-A1 KINASE INHIBITORS USEFUL FOR THE TREATMENT OF MYLEOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES DECIPHERA PHARMACEUTICALS, LLC (US) 2008-10-30 WO disclosed